Parschauer Karah Herdman
Insider CIK 1677455 · RARE EVP and General Counsel · EOLS Director · ARCT Director · ANEB Director · TNYA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-08-03 | 2026-08-04 | 1,900 | $24.92 | $47.3K | 92,562 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-08-03 | 2026-08-04 | 1,900 | $24.92 | $47.3K | 92,562 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-06-15 | 2026-06-15 | 1,899 | $24.62 | $46.8K | 94,462 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2026-05-28 | 2026-05-29 | 120,000 | — | $0 | 120,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2026-04-16 | 2026-04-20 | 49,960 | — | $0 | 49,960 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-04-16 | 2026-04-20 | 28,895 | — | $0 | 95,715 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-03-10 | 2026-03-10 | 3,508 | $22.67 | $79.5K | 66,820 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-03-06 | 2026-03-10 | 6,018 | $21.40 | $128.8K | 70,328 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2026-03-02 | 2026-03-03 | 8,135 | $22.80 | $185.5K | 76,346 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2026-03-01 | 2026-03-03 | 11,137 | — | $0 | 84,408 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2026-02-17 | 2026-02-19 | 45,559 | — | $0 | 77,742 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-09-12 | 2025-09-12 | 2,450 | $31.17 | $76.4K | 73,271 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2025-05-29 | 2025-05-30 | 107,400 | — | $0 | 107,400 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2025-03-12 | 2025-03-14 | 12,888 | $12.99 | $167.4K | 32,183 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2025-03-07 | 2025-03-11 | 11,146 | — | $0 | 11,146 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2025-03-07 | 2025-03-11 | 7,364 | — | $0 | 45,071 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-03-03 | 2025-03-04 | 12,846 | $42.10 | $540.8K | 75,287 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2025-03-01 | 2025-03-03 | 26,074 | — | $0 | 26,074 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-03-01 | 2025-03-03 | 14,494 | — | $0 | 69,690 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2025-03-01 | 2025-03-04 | 18,443 | — | $0 | 88,133 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-02-27 | 2025-03-03 | 760 | $42.75 | $32.5K | 54,991 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2025-02-27 | 2025-03-03 | 2,230 | $42.93 | $95.7K | 55,751 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2024-10-18 | 2024-10-21 | 34,000 | — | $0 | 34,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-06-12 | 2024-06-12 | 9,806 | $45.00 | $441.3K | 57,981 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2024-03-01 | 2024-03-05 | 31,400 | — | $0 | 31,400 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-03-01 | 2024-03-05 | 17,800 | — | $0 | 69,782 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2024-03-01 | 2024-03-05 | 3,756 | $53.76 | $201.9K | 67,340 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2024-03-01 | 2024-03-05 | 957 | — | $0 | 70,739 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2024-02-07 | 2024-02-09 | 9,377 | — | $0 | 9,377 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2024-02-07 | 2024-02-09 | 6,464 | — | $0 | 37,707 | SEC↗ |
| EOLS Evolus, Inc. | S Sale | 2024-01-30 | 2024-02-02 | 11,931 | $13.14 | $156.8K | 31,243 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2023-06-09 | 2023-06-12 | 29,532 | — | $0 | 29,532 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2023-05-04 | 2023-05-05 | 4,378 | $45.00 | $197.0K | 51,982 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2023-03-01 | 2023-03-03 | 39,400 | — | $0 | 39,400 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2023-03-01 | 2023-03-03 | 3,161 | $45.25 | $143.0K | 56,139 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-03-01 | 2023-03-03 | 2,663 | — | $0 | 37,101 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2023-03-01 | 2023-03-03 | 22,000 | — | $0 | 59,101 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2023-01-27 | 2023-01-31 | 11,789 | — | $0 | 11,789 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2023-01-27 | 2023-01-31 | 8,293 | — | $0 | 43,174 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2022-09-08 | 2022-09-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ANEB Anebulo Pharmaceuticals, I | A Award deriv | 2022-04-21 | 2022-10-03 | 30,425 | — | $0 | 30,425 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-03-07 | 2022-03-08 | 5,140 | $62.95 | $323.6K | 34,438 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2022-03-01 | 2022-03-03 | 24,900 | — | $0 | 24,900 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2022-03-01 | 2022-03-03 | 2,886 | $66.62 | $192.3K | 25,472 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2022-03-01 | 2022-03-03 | 14,000 | — | $0 | 39,578 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2022-01-24 | 2022-01-26 | 22,727 | — | $0 | 22,727 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2022-01-24 | 2022-01-26 | 15,568 | — | $0 | 34,881 | SEC↗ |
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2021-12-22 | 2021-12-23 | 19,495 | — | $0 | 19,495 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-10-14 | 2021-10-18 | 310 | $81.14 | $25.2K | 28,358 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2021-09-08 | 2021-09-09 | 7,336 | — | $0 | 17,664 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2021-09-08 | 2021-09-09 | 7,336 | $54.50 | $399.8K | 36,004 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-09-08 | 2021-09-09 | 7,336 | $100.65 | $738.4K | 28,668 | SEC↗ |
| ARCT Arcturus Therapeutics Hold | A Award deriv | 2021-06-18 | 2021-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-06-10 | 2021-06-11 | 1,329 | $100.00 | $132.9K | 28,668 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-05-06 | 2021-05-10 | 313 | $113.67 | $35.6K | 29,997 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2021-03-01 | 2021-03-03 | 11,000 | — | $0 | 11,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2021-03-01 | 2021-03-03 | 3,970 | $138.17 | $548.5K | 30,227 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 5,500 | — | $0 | 29,561 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2021-03-01 | 2021-03-03 | 4,636 | — | $0 | 34,197 | SEC↗ |
| EOLS Evolus, Inc. | A Award | 2021-02-05 | 2021-02-09 | 19,313 | — | $0 | 19,313 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-10-30 | 2020-11-02 | 9,903 | — | $0 | 25,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-10-30 | 2020-11-02 | 9,903 | $100.12 | $991.5K | 24,061 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-10-30 | 2020-11-02 | 9,903 | $54.50 | $539.7K | 33,871 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-10-28 | 2020-10-30 | 97 | — | $0 | 34,903 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-10-28 | 2020-10-30 | 97 | $100.00 | $9.7K | 23,968 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-10-28 | 2020-10-30 | 97 | $54.50 | $5.3K | 24,065 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-10-14 | 2020-10-16 | 325 | $88.00 | $28.6K | 23,968 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-10-08 | 2020-10-13 | 10,000 | — | $0 | 35,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-10-08 | 2020-10-13 | 10,000 | $95.00 | $950.0K | 24,293 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-10-08 | 2020-10-13 | 10,000 | $54.50 | $545.0K | 34,293 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-10-06 | 2020-10-07 | 10,000 | — | $0 | 17,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-10-06 | 2020-10-07 | 10,000 | $48.43 | $484.3K | 34,293 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-10-06 | 2020-10-07 | 10,000 | $90.00 | $900.0K | 24,293 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-09-23 | 2020-09-24 | 10,000 | — | $0 | 27,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-09-23 | 2020-09-24 | 10,000 | $85.00 | $850.0K | 24,293 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-09-23 | 2020-09-24 | 10,000 | $48.43 | $484.3K | 34,293 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2020-08-17 | 2020-08-19 | 10,000 | — | $0 | 45,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-08-17 | 2020-08-19 | 10,000 | $88.44 | $884.4K | 26,663 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-08-17 | 2020-08-19 | 2,370 | $88.39 | $209.5K | 24,293 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2020-08-17 | 2020-08-19 | 10,000 | $54.50 | $545.0K | 36,663 | SEC↗ |
| ARCT Arcturus Therapeutics Hold | A Award deriv | 2020-06-22 | 2020-06-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-06-20 | 2020-06-22 | 649 | $78.22 | $50.8K | 26,663 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2020-05-18 | 2020-05-19 | 2,722 | $74.72 | $203.4K | 27,312 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-05-06 | 2020-05-08 | 248 | $66.26 | $16.4K | 29,904 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-04-19 | 2020-04-21 | 248 | $58.57 | $14.5K | 30,152 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2020-03-01 | 2020-03-03 | 22,000 | — | $0 | 22,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 7,800 | — | $0 | 26,884 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2020-03-01 | 2020-03-03 | 5,634 | — | $0 | 32,518 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2020-03-01 | 2020-03-03 | 2,118 | $56.08 | $118.8K | 30,400 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2020-01-23 | 2020-01-24 | 23,458 | — | $0 | 23,458 | SEC↗ |
| ARCT Arcturus Therapeutics Hold | A Award deriv | 2019-10-25 | 2019-10-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARCT Arcturus Therapeutics Hold | A Award deriv | 2019-10-25 | 2019-10-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-10-14 | 2019-10-16 | 1,434 | — | $0 | 19,084 | SEC↗ |
| EOLS Evolus, Inc. | A Award deriv | 2019-07-15 | 2019-07-17 | 26,163 | — | $0 | 26,163 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2019-06-24 | 2019-06-24 | 1,226 | $61.50 | $75.4K | 17,650 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2019-06-21 | 2019-06-24 | 1,489 | $63.01 | $93.8K | 18,876 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-06-20 | 2019-06-24 | 649 | $63.48 | $41.2K | 20,365 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-05-06 | 2019-05-07 | 1,434 | — | $0 | 21,014 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2019-04-29 | 2019-04-30 | 468 | $68.30 | $32.0K | 19,580 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-04-19 | 2019-04-23 | 248 | $64.43 | $16.0K | 20,048 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2019-03-05 | 2019-04-17 | 886 | $65.52 | $58.1K | 20,296 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-03-01 | 2019-04-17 | 21,500 | — | $0 | 21,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-03-01 | 2019-04-17 | 7,000 | — | $0 | 21,182 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2019-03-01 | 2019-03-04 | 21,500 | — | $0 | 21,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2019-03-01 | 2019-03-04 | 860 | $67.55 | $58.1K | 20,321 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2019-03-01 | 2019-03-04 | 7,000 | — | $0 | 21,181 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise deriv | 2018-08-21 | 2018-10-09 | 5,000 | — | $0 | 55,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-08-21 | 2018-10-09 | 5,000 | $78.53 | $392.6K | 14,181 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | M Exercise | 2018-08-21 | 2018-10-09 | 5,000 | $54.50 | $272.5K | 19,181 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-08-21 | 2018-08-21 | 5,000 | $78.53 | $392.6K | 9,181 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-06-21 | 2018-06-21 | 1,226 | $82.77 | $101.5K | 14,181 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-06-20 | 2018-06-20 | 649 | $85.31 | $55.4K | 15,407 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | S Sale | 2018-05-10 | 2018-05-10 | 1,465 | $60.00 | $87.9K | 16,056 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-04-19 | 2018-04-19 | 1,431 | — | $0 | 17,521 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2018-03-01 | 2018-03-05 | 37,000 | — | $0 | 37,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2018-03-01 | 2018-03-05 | 7,500 | — | $0 | 16,295 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2018-03-01 | 2018-03-05 | 205 | $48.43 | $9.9K | 16,090 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | F Tax w/h | 2017-06-20 | 2017-06-21 | 705 | $63.38 | $44.7K | 8,795 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2017-03-01 | 2017-03-01 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2017-03-01 | 2017-03-01 | 2,000 | — | $0 | 9,500 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award deriv | 2016-06-20 | 2016-06-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| RARE Ultragenyx Pharmaceutical | A Award | 2016-06-20 | 2016-06-22 | 7,500 | — | $0 | 7,500 | SEC↗ |